| Unique ID issued by UMIN | UMIN000022036 |
|---|---|
| Receipt number | R000025184 |
| Scientific Title | Comparison of the effects of single predonine and predonine-iguratimod therapy on the old elderly onset arthritis.randomized controlled trial. |
| Date of disclosure of the study information | 2016/08/01 |
| Last modified on | 2020/10/26 09:49:56 |
Comparison of the effects of single predonine and predonine-iguratimod therapy on the old elderly onset arthritis.randomized controlled trial.
The effects of iguratimod therapy on the elderly onset arthritis.
Comparison of the effects of single predonine and predonine-iguratimod therapy on the old elderly onset arthritis.randomized controlled trial.
The effects of iguratimod therapy on the elderly onset arthritis.
| Japan |
elderly onset arthritis
| Clinical immunology |
Others
NO
To compare the effects and the safety of single predonine and predonine-iguratimod therapy on the elderly onset arthritis.
Efficacy
Others
Pragmatic
Not applicable
Revival rate (during two years from start of therapy)
dose of steroid(mg/day)
(after 6.12.18.24 month from start of therapy)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Pseudo-randomization
2
Treatment
| Medicine |
Predonine single group
Predonine treatment protocol starting with 15 mg/day for 4weeks and,12.5 mg/day a for 4 weeks,10 mg/day for 4-6 weeks, and tapering for 1mg/4-8 weeks until completion of treatment.
The intervention period are about two years.
Predonine-iguratimode group Predonine treatment protocol starting with 15mg/day for 4weeks and,12.5 mg/day a for 4weeks,10mg/day for 4-6 weeks,and tapering for 1mg/4-8 weeks until completion of treatment.
Iguratimod treatment protocol starting with 25mg/day for 4weeks.and increase to 50mg/day (When there is not tolerability,even 25mg/day is possible)
The intervention period are about two years.
| 50 | years-old | <= |
| Not applicable |
Male and Female
Arthritis patient diagnosis to after 50 years old.
Patient not have a poor-prognosis gene (rheumatoid factor,antiCCP antibody, Sore bone in X-rays,high disease activity).
Predonine-iguratimode intolerable patients.
Patients not treated with predonine-iguratimode and such as an immunosuppressive drug or the biologicals within one month.
Pregnant or possibly pregnant patients.
50
| 1st name | Masanori |
| Middle name | |
| Last name | Funauchi |
Kinki University Facalty of Medicine
Division of Hematology and Rheumatology
589-0014
377-2 Ohnohigashi, Osakasayama, Osaka Japan
0723660221
mn-funa@med.kindai.ac.jp
| 1st name | Shinkai |
| Middle name | |
| Last name | Ri |
Kinki University Facalty of Medicine
Division of Hematology and Rheumatology
589-0014
377-2 Ohnohigashi, Osakasayama, Osaka Japan
0723660221
http://www.med.kindai.ac.jp/rinri/index.html
jinhai@med.kindai.ac.jp
Kinki University Faculty of Medicine, Division of Hematology and Rheumatology
Kinki University Faculty of Medicine, Division of Hematology and Rheumatology
Self funding
Kinki University medical department ethic screening committee
377-2 Ohnohigashi, Osakasayama, Osaka Japan
0723660221
gakumu@med.kindai.ac.jp
NO
近畿大学医学部附属病院 (大阪府) Kinki University Faculty of Medicine(Osaka)
| 2016 | Year | 08 | Month | 01 | Day |
Unpublished
No longer recruiting
| 2016 | Year | 08 | Month | 01 | Day |
| 2016 | Year | 08 | Month | 01 | Day |
| 2016 | Year | 08 | Month | 01 | Day |
| 2022 | Year | 08 | Month | 01 | Day |
| 2022 | Year | 08 | Month | 01 | Day |
| 2022 | Year | 08 | Month | 01 | Day |
| 2022 | Year | 08 | Month | 01 | Day |
| 2016 | Year | 04 | Month | 24 | Day |
| 2020 | Year | 10 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025184